BriaCell Therapeutics Corp. Common Shares (NASDAQ: BCTX)
$0.95
+0.0200 ( +2.15% ) 103.8K
BriaCell Therapeutics Corp is an immuno-oncology-focused biotechnology company. The group develops targeted and safe approaches for the management of cancer. BriaCell is conducting a Phase I/IIa clinical trial of Bria-IMT in metastatic breast cancer. Additionally, it is developing Bria-OTS, off-the-shelf personalized immunotherapy, for the treatment of advance-stage breast cancer by matching the patient's HLA type.
Market Data
Open
$0.95
Previous close
$0.93
Volume
103.8K
Market cap
$17.37M
Day range
$0.88 - $0.96
52 week range
$0.85 - $7.59
SEC Fillings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 10-q | Quarterly Reports | 54 | Dec 14, 2023 |
| 8-k | 8K-related | 23 | Dec 14, 2023 |
| 8-k | 8K-related | 15 | Nov 30, 2023 |
| 8-k | 8K-related | 15 | Nov 03, 2023 |
| 10-k | Annual reports | 88 | Oct 25, 2023 |
| 8-k | 8K-related | 26 | Oct 25, 2023 |
| 8-k | 8K-related | 15 | Sep 08, 2023 |
| 8-k | 8K-related | 22 | Sep 07, 2023 |
| 8-k | 8K-related | 15 | Aug 31, 2023 |
| 8-k | 8K-related | 15 | Aug 31, 2023 |